Johnson & Johnson's Management Presents at Morgan Stanley Healthcare Conference Call

9/13/17

Thanks for joining us here. My name is David Lewis, Medical Device Analyst from Morgan Stanley. Thanks for joining us here to round out medical device and pharmaceutical coverage here for the Morgan Stanley Healthcare Conference day-three. It's my pleasure to have with us here Johnson & Johnson and Senior Member Management, Dominic Caruso, Chief Financial Officer. Jason is going to read us some Safe Harbor statements, and we’re going to jump right in the Q&A.

Dominic Caruso

Thanks, David. Good afternoon. Please be aware that some statements made today may be considered forward-looking. Please refer to our SEC filings, in particular, our 10-K, which discussed risks and uncertainties that could cause results to differ materially from those projected today. In addition, we may refer to non-GAAP measures. See our Web site at investor.jnj.com for reconciliations to comparable GAAP measures. Finally, all remarks regarding financial performance represent results through and including the second quarter of 2017.

READ FULL ARTICLE HERE

Recent Deals

Interested in advertising your deals? Contact Edwin Warfield.